NCT00087061View on ClinicalTrials.gov

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2004

Study Completion Date

June 30, 2005

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

gimatecan

Trial Locations (1)

90095

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00087061 - Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma | Biotech Hunter | Biotech Hunter